Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Ardelyx, Axena, Beyond Air, Biontech, Cassava, Celularity, Cliniquantum, Dario, Erasca, Genedx, Glooko, Guardant, Joyo, Mink, Neuronos, Neurothera, Novo Nordisk, Quest, Scisparc, XLT, Zevra.

Clinical updates for biopharma and med tech, including data readouts and publications: Aptevo, Arcutis, Ascletis, Celcuity, Citius, Edgewise, Excellthera, Kainova, Neurosense, NMD, SAB, Satellos, Telix, Tonix, Vertex.

Biopharma and med-tech companies raising money in public or private financings, including: Calidi, Longeveron, Max, May Health, Neuros, Theralase, Technomark, Trinity.

New hires and promotions in the biopharma and med-tech industries, including: Aeon, Butterfly, Dermata, H. Lundbeck, MBX, Odyssey, OSE, Qlaris, Sandoz, Santhera, Vect-Horus.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, BMS, Chiesi, Claritas, Daiichi, Immunitybio, Incyte, Johnson & Johnson, Junshi, MBX, Nanosonics, PMV, Precision, Protalix, Sangamo, Savara.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Actuate, Baymedica, DT-Axis, Eledon, Etcembly, Fujitsu, Galecto, Inmed, Kuva Labs, Kyron.bio, Lisata, Newcelx, Servier, Zelluna.

Clinical updates for biopharma and med tech, including data readouts and publications: Atamyo, Benitec, Biofrontera, BMS, Bonesupport, Castle, Crestone, Dianthus, Dyne, Ipsen, ITF, Keros, Novabridge, Novelmed, Numares, Pfizer, Pulse, Regeneron, Relmada, Roche, Santhera, Spyglass, TG, Tris, Visara, Xenon.

Biopharma and med-tech companies raising money in public or private financings, including: AN2, Defence, Invea, Korro, Lyell, Relmada, SS Innovations, Telo Genomics.

New hires and promotions in the biopharma and med-tech industries, including: Biomx, Ionis, LB, Lobe Sciences, Lyell, Spruce, Tevogen.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Accord, Asieris, Claritas, Drug Farm, Foresee, Glenmark, Nxera, Hua Medicine, Innocare, Innovent, Meiji, Pepgen, Pharmaessentia, Protagonist, Sanofi, Sciwind, Sumitomo, Takeda.